The Menarini Pharmaceutical Group, with headquarters in Florence, Italy, has appointed Elcin Barker Ergun as group chief executive. Ms Ergun comes to the job with experience in both the technology and pharmaceutical sectors, most recently as head of new business at Merck KGaA’s healthcare division in Boston, US. Prior to this, she was head of global commercial affairs for Merck Serono. Ms Ergun trained as an engineer and has a master of business administration degree from the French business school INSEAD.
Menarini announced the appointment on 12 September 2019.
Copyright 2019 Evernow Publishing Ltd